Concepedia

Alina Simerzin

AS

Statistics

Publications

8

Citations

683

H-Index

8

Active since

2010

Affiliations

Hadassah Medical Center(Current)

Hebrew University of Jerusalem

University Medical Center Hamburg-Eppendorf

Universität Hamburg

Weizmann Institute of Science

Alina Simerzin is an author at Hadassah Medical Center specializing in molecular biology, medicine, and oncology.

ORCID

Publications per year

2010–2022

8

Publications

8

Mutant KRAS is a druggable target for pancreatic cancer

Elina Zorde Khvalevsky, Racheli Gabai, Itzhak H. Rachmut et al. · Proceedings of the National Academy of Sciences · 2013 · 290 citations · Full text

, , +17

Metabolic Circuit Involving Free Fatty Acids, microRNA 122, and Triglyceride Synthesis in Liver and Muscle Tissues

Chofit Chai, Mila Rivkin, Liav Berkovits et al. · Gastroenterology · 2017 · 112 citations

, , +14

Combined hepatocellular-cholangiocarcinoma derives from liver progenitor cells and depends on senescence and IL-6 trans-signaling

Nofar Rosenberg, Matthias Van Haele, Tali Lanton et al. · Journal of Hepatology · 2022 · 70 citations · Full text

, , +16

Inflammation-Induced Expression and Secretion of MicroRNA 122 Leads to Reduced Blood Levels of Kidney-Derived Erythropoietin and Anemia

Mila Rivkin, Alina Simerzin, Elina Zorde‐Khvalevsky et al. · Gastroenterology · 2016 · 64 citations · Full text

, , +17

The liver‐specific microRNA‐122*, the complementary strand of microRNA‐122, acts as a tumor suppressor by modulating the p53/mouse double minute 2 homolog circuitry

Alina Simerzin, Elina Zorde‐Khvalevsky, Mila Rivkin et al. · Hepatology · 2016 · 51 citations · Full text

, , +16

1–5 of 8